KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer

J Cicenas, K Kvederaviciute, I Meskinyte… - Cancers, 2017 - mdpi.com
Pancreatic cancer is a disease that has a very high fatality rate and one of the highest
mortality ratios among all major cancers, remaining the fourth leading cause of cancer …

Targeting the ERK signaling pathway in melanoma

P Savoia, P Fava, F Casoni, O Cremona - International journal of …, 2019 - mdpi.com
The discovery of the role of the RAS/RAF/MEK/ERK pathway in melanomagenesis and its
progression have opened a new era in the treatment of this tumor. Vemurafenib was the first …

Therapeutic insights on ferroptosis in Parkinson's disease

K Thapa, H Khan, N Kanojia, TG Singh, A Kaur… - European journal of …, 2022 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder that alters either motor or non-
motor activities. Dopamine-based medications can help alleviate symptoms at an early …

Kinases and cancer

J Cicenas, E Zalyte, A Bairoch, P Gaudet - Cancers, 2018 - mdpi.com
Protein kinases are a large family of enzymes catalyzing protein phosphorylation. The
human genome contains 518 protein kinase genes, 478 of which belong to the classical …

BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy

ZN Li, L Zhao, LF Yu, MJ Wei - Gastroenterology report, 2020 - academic.oup.com
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and
30% of patients with CRC experience metastasis. Patients with metastatic colorectal cancer …

ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras–ERK signaling

D Zhu, J Zhou, J Zhao, G Jiang, X Zhang… - Journal of cellular …, 2019 - Wiley Online Library
ZC3H13 is a canonical CCCH zinc finger protein, which harbors a somatic frame‐shift
mutation in colorectal cancer (CRC). However, its expression and biological function were …

The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response

G Wang, D Xu, Z Zhang, X Li, J Shi, J Sun… - NPJ precision …, 2021 - nature.com
An emerging body of evidence has recently recognized the coexistence of epithelial-
mesenchymal transition (EMT) and immune response. However, a systems-level view and …

Molecular aspects and therapeutic implications of herbal compounds targeting different types of cancer

A Sharma, L Sharma, SK Nandy, N Payal, S Yadav… - Molecules, 2023 - mdpi.com
Due to genetic changes in DNA (deoxyribonucleic acid) sequences, cancer continues to be
the second most prevalent cause of death. The traditional target-directed approach, which is …

JNK, p38, ERK, and SGK1 inhibitors in cancer

J Cicenas, E Zalyte, A Rimkus, D Dapkus, R Noreika… - Cancers, 2017 - mdpi.com
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a
range of biological processes implicated in the response to growth factors like latelet …

Options of therapeutics and novel delivery systems of drugs for the treatment of melanoma

H Wang, TT Tran, KT Duong, T Nguyen… - Molecular …, 2022 - ACS Publications
Melanoma is one of the most severe cancerous diseases. The cells employ multiple
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …